A case of HER-2(+) squamous cell breast carcinoma: An unusual presentation of an unusual clinical entity

European Journal of Surgical Oncology

Volumn 32, Issue 10, 2006, Pages 1250-1251

  Karamouzis, M V ^a   Fida, A ^a   Apostolikas, N ^a   Rigatos, G ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

Breast carcinoma; HER 2; Squamous carcinoma

Indexed keywords

AROMATASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; PROGESTERONE RECEPTOR;

AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER GRADING; CANCER RELAPSE; CASE REPORT; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MASTECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; RECEPTOR, ERBB-2;

EID: 33751187133     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.05.008     Document Type: Article

References (6)

1. Hennessy B.T., Krishnamurthy S., Giordano S., et al. Squamous cell carcinoma of the breast. J Clin Oncol 31 (2005) 7827-7835
2. Behranwala K.A., Nasiri N., Abdullah N., Trott P.A., and Gui G.P. Squamous cell carcinoma of the breast: clinicopathologic implications and outcome. Eur J Surg 29 (2003) 386-389
3. Cardoso F., Leal C., and Meira A. Squamous cell carcinoma of the breast. Breast 9 (2000) 315-319
4. Ross J.S., Fletcher J.A., Bloom K.J., et al. Targeted therapy in breast cancer: the HER-2/neu gene and protein. Mol Cell Proteomics 3 (2004) 379-398
5. Bellino R., Arisio R., D'Addato F., et al. Anticancer Res 23 (2003) 669-673
6. Bundred N.J., and Barnes N.L. Potential use of COX-2-aromatase inhibitor combinations in breast cancer. Br J Cancer 93 Suppl. 1 (2005) S10-S15